Latest Biotech News

Interim results from the phase II COCOON trial showed that proactive skincare reduced dermatologic toxicity by 50% in patients receiving frontline treatment for EGFR-mutant non-small cell lung...

Caris Life Sciences launched Caris ChromoSeq, a combined whole-genome sequencing and whole-transcriptome assay intended to improve comprehensive genomic evaluation of myeloid malignancies. The...

Researchers reported in the British Journal of Cancer that targetable molecular markers help define antiprogestin-resistant breast cancer, particularly in luminal disease where endocrine...

A new study reported by researchers on circulating glycocholic acid (GCA) links bile-acid biology to the performance of immune checkpoint therapy in colorectal cancer. The work suggests GCA can...

Biomedical engineers at the University of North Carolina at Chapel Hill and North Carolina State University developed an injectable hemostatic microgel designed for neonatal-specific clotting,...

Researchers from The Jackson Laboratory and collaborators reported an epigenetic approach that restores a tumor suppressor in acute myeloid leukemia by inhibiting KDM4 enzymes. The work, published...

SeekGene said it is expanding internationally with multi-omics offerings built on its SeekOne Digital Droplet microfluidics platform, targeting Europe as a first priority and planning later...

A plant biotech study highlighted seed dormancy as a factor that could change how gene drives perform in real-world settings. Researchers reported that dormancy dynamics can influence the timing...

FDA approved Rocket Pharmaceuticals’ gene therapy Kresladi (marne-cel) for leukocyte adhesion deficiency type I, according to the company’s March approvals update. FDA also issued a rare pediatric...

Phase I dose-expansion findings tied biomarker analysis to clinical monitoring for AZD2811 in relapsed or refractory small-cell lung cancer (SCLC), researchers reported in a featured update. The...

Researchers at The Jackson Laboratory (JAX), working with collaborators, reported that inhibiting KDM4 can epigenetically reactivate the tumor suppressor ZBTB7A in acute myeloid leukemia (AML)...

Syneron Bio closed a $150 million Series B to support its macrocyclic peptide development platform, after earlier funding and a multibillion-dollar biobucks deal with AstraZeneca. The round...

A phase II GETNE-DUTHY trial tested a combination of durvalumab and tremelimumab in advanced thyroid cancer, according to a reported study update. The trial, led by Capdevila, Hernando,...

TriNetX will link genomic and proteomic data for drug discovery and development with Regeneron through exclusive, secure access to de-identified health data from about 300 million individuals. The...

A real-world study published in Nature Communications evaluated comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes. Kim, Bu, Blacketer and colleagues...

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University developed an injectable microgel intended to reduce bleeding in infants during surgery. In...

Trump signed an executive order imposing a 100% ad valorem tariff on imported brand-name patented pharmaceuticals and associated ingredients under Section 232, citing U.S. import reliance. The...

Clinicians and researchers offering early access to Grail’s multi-cancer early detection (MCED) test are waiting for the full NHS trial readout after the endpoint miss, according to the report....

FDA has approved Rocket Pharmaceuticals’ gene therapy Kresladi (marne-cel) for leukocyte adhesion deficiency type I, and the therapy has earned a rare pediatric disease priority review voucher...

New oncology findings highlight how biomarker analysis is moving from retrospective validation toward real-time decision support. In relapsed or refractory small-cell lung cancer, a phase I...